Literature DB >> 12525766

Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women.

Zhenhuan Zhang1, Hiroko Yamashita, Tatsuya Toyama, Yoko Omoto, Hiroshi Sugiura, Yasuo Hara, Nobuhiro Haruki, Shunzo Kobayashi, Hirotaka Iwase.   

Abstract

BACKGROUND: An estrogen receptor (ER) alpha variant with an A-to-G transition at nucleotide 908 (A908G) has been identified in typical hyperplastic mammary epithelium. This somatic mutation, which induces a Lys-to-Arg substitution at residue 303 within exon 4 at the border of the hinge and hormone-binding domains of the ER alpha, shows increased sensitivity to estrogen compared with wild-type ER alpha.
METHODS: To investigate whether this mutation was present in breast lesions, we performed mutation analyses using the PCR-restriction fragment length polymorphism (RFLP) method in 7 cases of hyperplasia, 18 cases of benign breast tumor, 26 cases of ductal carcinoma in situ (DCIS) and 215 cases of invasive ductal carcinoma (IDC). When we extracted DNA, the hyperplastic epithelium and cancer cells of DCIS were microdissected. We also performed direct sequencing analysis from 7 randomly-selected representative cases of hyperplasia, 9 cases of benign breast tumors, 11 cases of DCIS and 20 cases of IDC.
RESULTS: No A908G mutation was found in the ER alpha gene in these breast lesions.
CONCLUSION: This mutation might be absent or occur in so few cells as to be undetectable by PCR-RFLP or direct sequencing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525766     DOI: 10.1007/bf02967628

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  10 in total

1.  Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.

Authors:  Ines Barone; Stefania Catalano; Luca Gelsomino; Stefania Marsico; Cinzia Giordano; Salvatore Panza; Daniela Bonofiglio; Gianluca Bossi; Kyle R Covington; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

Review 2.  Estrogen receptor mutations and changes in downstream gene expression and signaling.

Authors:  Ines Barone; Lauren Brusco; Suzanne A W Fuqua
Journal:  Clin Cancer Res       Date:  2010-04-28       Impact factor: 12.531

3.  Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment.

Authors:  Chiara Ghimenti; Maurizia Mello-Grand; Lea Regolo; Alberto Zambelli; Giovanna Chiorino
Journal:  Exp Ther Med       Date:  2010-09-17       Impact factor: 2.447

Review 4.  The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.

Authors:  Sasha M Pejerrey; Derek Dustin; Jin-Ah Kim; Guowei Gu; Yassine Rechoum; Suzanne A W Fuqua
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

Review 5.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

6.  BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

Authors:  Yongxian Ma; Saijun Fan; Changyan Hu; Qinghui Meng; Suzanne A Fuqua; Richard G Pestell; York A Tomita; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2009-11-03

7.  Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.

Authors:  Ines Barone; Yukun Cui; Matthew H Herynk; Arnoldo Corona-Rodriguez; Cinzia Giordano; Jennifer Selever; Amanda Beyer; Sebastiano Andò; Suzanne A W Fuqua
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

8.  Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.

Authors:  Matthew H Herynk; Irma Parra; Yukun Cui; Amanda Beyer; Meng-Fen Wu; Susan G Hilsenbeck; Suzanne A W Fuqua
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531

9.  The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

Authors:  Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Joseph Geradts; Chad A Livasy; Harsharan Singh; Beth Newman; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2005-09-06       Impact factor: 6.466

10.  Hypersensitive K303R oestrogen receptor-alpha variant not found in invasive carcinomas.

Authors:  Michael P A Davies; Penny A O'Neill; Helen Innes; D Ross Sibson
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.